Montanaro Asset Management LTD Maxcyte, Inc. Transaction History

Montanaro Asset Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$4.03 - $5.89 $3.63 Million - $5.3 Million	-900,000 Reduced 96.88%	29,000 $143,000
Q1 2022 May 12, 2022	SELL	$5.26 - $10.84 $2.37 Million - $4.88 Million	-450,000 Reduced 32.63%	929,000 $6.56 Million
Q4 2021 Feb 11, 2022	SELL	$8.87 - $12.94 $10.4 Million - $15.1 Million	-1,170,000 Reduced 45.9%	1,379,000 $14.1 Million
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $31.1 Million - $43.8 Million	2,549,000 New	2,549,000 $31 Million

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $451M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Montanaro Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Montanaro Asset Management LTD with notifications on news.